Published in Women's Health Weekly, January 8th, 1996
Femstat 3 was switched from prescription-only to an over-the-counter medicine by the U.S. Food and Drug Administration (FDA) just before Christmas 1995. Every other OTC medicine for vaginal yeast infections requires seven days of treatment.
Manufactured by Switzerland's Roche Holding Ltd., the drug will be sold in the United States by Procter & Gamble. The company said December 27, 1995, that Femstat would be on store shelves by spring 1996, but it had not yet set a price.
Femstat contains the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.